Latest Insider Transactions at A Ikido Pharma Inc. (AIKI)
This section provides a real-time view of insider transactions for A Ikido Pharma Inc. (AIKI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of AIkido Pharma Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of AIkido Pharma Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 26
2022
|
Anthony Hayes CEO |
BUY
Grant, award, or other acquisition
|
Direct |
78,588
+48.33%
|
$471,528
$6.0 P/Share
|
|
Jul 30
2021
|
Gregory James Blattner Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+28.81%
|
$0
$0.88 P/Share
|
|
Jul 30
2021
|
Robert Frederick Dudley Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
$0
$0.88 P/Share
|
|
Jul 30
2021
|
Tim S Ledwick Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+26.38%
|
$0
$0.88 P/Share
|
|
Jul 30
2021
|
Paul Le Mire Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+33.33%
|
$0
$0.88 P/Share
|
|
Jul 30
2021
|
Kyle Michael Wool President |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+50.0%
|
$0
$0.88 P/Share
|
|
Jul 30
2021
|
Robert J Vander Zanden Director |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+26.72%
|
$0
$0.88 P/Share
|
|
May 03
2021
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+11.31%
|
$0
$0.99 P/Share
|
|
Apr 29
2021
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+12.75%
|
$0
$0.99 P/Share
|
|
Apr 22
2021
|
Anthony Hayes CEO |
BUY
Open market or private purchase
|
Direct |
10,000
+14.61%
|
$0
$0.93 P/Share
|